Nicholas Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-48,325
| Closed | -$4.73M | – | 227 |
|
|
2019
Q3 | $4.73M | Sell |
48,325
-40
| -0.1% | -$3.92K | 0.11% | 189 |
|
|
2019
Q2 | $6.34M | Sell |
48,365
-225
| -0.5% | -$29.5K | 0.14% | 158 |
|
|
2019
Q1 | $6.57M | Buy |
48,590
+85
| +0.2% | +$11.5K | 0.16% | 150 |
|
|
2018
Q4 | $4.72M | Hold |
48,505
| – | – | 0.12% | 179 |
|
|
2018
Q3 | $6.74M | Buy |
48,505
+105
| +0.2% | +$14.6K | 0.15% | 155 |
|
|
2018
Q2 | $6.01M | Buy |
48,400
+5,630
| +13% | +$699K | 0.14% | 159 |
|
|
2018
Q1 | $4.77M | Buy |
+42,770
| New | +$4.77M | 0.11% | 182 |
|
|
2017
Q2 | – | Sell |
-50,265
| Closed | -$6.09M | – | 223 |
|
|
2017
Q1 | $6.09M | Buy |
50,265
+40
| +0.1% | +$4.85K | 0.14% | 131 |
|
|
2016
Q4 | $6.15M | Buy |
50,225
+5,020
| +11% | +$614K | 0.14% | 130 |
|
|
2016
Q3 | $5.54M | Buy |
45,205
+9,990
| +28% | +$1.22M | 0.12% | 131 |
|
|
2016
Q2 | $4.11M | Hold |
35,215
| – | – | 0.08% | 153 |
|
|
2016
Q1 | $4.9M | Buy |
35,215
+2,685
| +8% | +$374K | 0.1% | 127 |
|
|
2015
Q4 | $6.21M | Hold |
32,530
| – | – | 0.12% | 116 |
|
|
2015
Q3 | $5.09M | Hold |
32,530
| – | – | 0.1% | 120 |
|
|
2015
Q2 | $5.88M | Buy |
32,530
+17,520
| +117% | +$3.17M | 0.1% | 124 |
|
|
2015
Q1 | $2.6M | Buy |
+15,010
| New | +$2.6M | 0.05% | 199 |
|